An Isocaloric Low Glycemic Index Diet Improves Insulin Sensitivity in Women with Polycystic Ovary Syndrome

被引:32
作者
Barr, Suzanne [1 ,2 ]
Reeves, Sue [2 ]
Sharp, Kay [2 ]
Jeanes, Yvonne M. [2 ]
机构
[1] Kings Coll London, Diabet & Nutr Sci Div, London SE1 9NH, England
[2] Univ Roehampton, Dept Life Sci, London, England
关键词
Polycystic ovary syndrome; Glycemic index; Insulin resistance; LOAD VALUES; PHYSICAL-ACTIVITY; FAT DISTRIBUTION; LIPID PROFILE; PREVALENCE; OVERWEIGHT; RESISTANCE; PHYSIOLOGY; PLASMA; RISK;
D O I
10.1016/j.jand.2013.06.347
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 5% to 10% of women worldwide. Approximately half of women with PCOS are lean, yet may still present with central obesity and metabolic disturbances. Low-glycemic index (GI) dietary intervention studies have demonstrated improvements in insulin sensitivity in insulin-resistant populations; however, there is little evidence of this effect in women with PCOS. This research aimed to determine the efficacy of an isocaloric low-GI dietary intervention on insulin sensitivity, independent of weight change, in women with PCOS. A nonrandomized 12-week low-GI dietary intervention, preceded by a 12-week habitual diet control phase and proceeded by a 12-week follow-up phase was conducted. Dietary intake, body composition, and metabolic risk markers were determined at baseline, after completion of the habitual diet control phase, and after the low-GI dietary intervention. Twenty-six participants were recruited at baseline, 22 commenced and 21 participants completed the low-GI dietary intervention phase. The primary outcome was change in insulin sensitivity. Secondary outcomes included assessment of changes to lipids, body composition, and estimated macronutrient intake. Repeated measures analysis of variance with Bonferroni correction were used to detect changes to outcomes across study timepoints. Twenty-one women with PCOS with mean (standard deviation) age of 32.1 +/- 6.7 years completed the 12-week low-GI dietary intervention. As expected, no significant changes occurred during the 12-week habitual diet Control phase. However, during the dietary intervention phase, dietary Cl decreased from 54.5 +/- 3.5 to 48.6 +/- 5.1 (P<0.001) with a concurrent small reduction in saturated fat intake (12.4%+/- 3% to 11.7%+/- 3% contribution from energy, P=0.03), despite no specific recommendations to modify fat intake. Measures of insulin sensitivity and nonesterified fatty acid improved after intervention (P=0.03 and P=0.01, respectively). This is the first study to implement an isocaloric low-GI diet in women with PCOS and findings may contribute to the limited research in this area.
引用
收藏
页码:1523 / 1531
页数:9
相关论文
共 39 条
  • [31] Methodology for adding glycemic index and glycemic load values to 24-hour dietary recall database
    Olendzki, Barbara C.
    Ma, Yunsheng
    Culver, Annie L.
    Ockene, Ira S.
    Griffith, Jennifer A.
    Hafner, Andrea R.
    Hebert, James R.
    [J]. NUTRITION, 2006, 22 (11-12) : 1087 - 1095
  • [32] Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men
    Rizkalla, SW
    Taghrid, L
    Laromiguiere, M
    Huet, D
    Boillot, J
    Rigoir, A
    Elgrably, F
    Slama, G
    [J]. DIABETES CARE, 2004, 27 (08) : 1866 - 1872
  • [33] Polycystic ovary syndrome, a pathway to type 2 diabetes
    Sir-Petermann, T
    [J]. NUTRITION, 2005, 21 (11-12) : 1160 - 1163
  • [34] A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome
    Stamets, K
    Taylor, DS
    Kunselman, A
    Demers, LM
    Pelkman, CL
    Legro, RS
    [J]. FERTILITY AND STERILITY, 2004, 81 (03) : 630 - 637
  • [35] Dietary glycaemic index and glycaemic load in the European Prospective Investigation into Cancer and Nutrition
    van Bakel, M. M. E.
    Kaaks, R.
    Feskens, E. J. M.
    Rohrmann, S.
    Welch, A. A.
    Pala, V.
    Avloniti, K.
    van der Schouw, Y. T.
    van der A, D. L.
    Du, H.
    Halkjaer, J.
    Tormo, M. J.
    Cust, A. E.
    Brighenti, F.
    Beulens, J. W.
    Ferrari, P.
    Biessy, C.
    Lentjes, M.
    Spencer, E. A.
    Panico, S.
    Masala, G.
    Bueno-de-Mesquita, H. B.
    Peeters, P. H. M.
    Trichopoulou, A.
    Psaltopoulou, T.
    Clavel-Chapelon, F.
    Touvier, M.
    Skeie, G.
    Rinaldi, S.
    Sonestedt, E.
    Johansson, I.
    Schulze, M.
    Ardanaz, E.
    Buckland, G.
    Tjonneland, A.
    Overvad, K.
    Bingham, S.
    Riboli, E.
    Slimani, N.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2009, 63 : S188 - S205
  • [36] Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights
    Westerveld, H. E.
    Hoogendoorn, M.
    de Jong, A. W. F.
    Goverde, A. J.
    Fauser, B. C. J. M.
    Dallinga-Thie, G. M.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2008, 119 (03) : 223 - 241
  • [37] BENEFICIAL EFFECT OF A LOW GLYCEMIC INDEX DIET IN TYPE-2 DIABETES
    WOLEVER, TMS
    JENKINS, DJA
    VUKSAN, V
    JENKINS, AL
    BUCKLEY, GC
    WONG, GS
    JOSSE, RG
    [J]. DIABETIC MEDICINE, 1992, 9 (05) : 451 - 458
  • [38] Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome
    Wright, CE
    Zborowski, JV
    Talbott, EO
    Mchugh-Pemu, K
    Youk, A
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (08) : 1026 - 1032
  • [39] The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome
    Yucel, Aykan
    Noyan, Volkan
    Sagsoz, Nevin
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 126 (01) : 81 - 86